For every individual diagnosed with blood cancer, can you envision life free of cancer after treatment?

And so can Tom Whitehead, co-founder of the Emily Whitehead Foundation.

He’s joining us to share his family’s personal story about life after leukemia, and their efforts to support research on innovative treatments, at our Global Oncohematology Summit, streaming live September 13 and 14.

 

I’ll be there

A testimonial from a cancer survivor on CAR T-cell therapy

 

“When you save a child, you save a family.”

Tom Whitehead
Co-founder of the Emily Whitehead Foundation

Standard treatment failed Emily Whitehead twice; then, she became the first successful pediatric CAR T-cell recipient. Now her parents Tom and Kari Whitehead are doing all they can to help others like her, working through their foundation to raise awareness and funding to support research on innovative treatments for childhood cancers.

Take the I Can pledge – a decision that improves patients’ lives – and join us to hear the Whitehead family’s story firsthand. .

 

Reserve your space

We can’t wait to see you there!

Kind regards,

Your QIAGEN Oncohematology team

PS – In addition to hearing directly from cancer survivors, we’ve organized a great lineup of speakers specializing in different blood cancer malignancies. Be sure to take a look at the full, two-day agenda.

Sample to Insight